BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 16478744)

  • 1. Gene promoter methylation in prostate tumor-associated stromal cells.
    Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
    J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abberant methylation of p16, HIC1, N33 and GSTP1 genes in tumor epitelium and tumor-associated stromal cells of prostate cancer].
    Kekeeva TV; Popova OP; Shegaĭ PV; Alekseev BIa; Adnreeva IuIu; Zaletaev DV; Nemtsova MV
    Mol Biol (Mosk); 2007; 41(1):79-85. PubMed ID: 17380894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease.
    Singal R; Ferdinand L; Reis IM; Schlesselman JJ
    Oncol Rep; 2004 Sep; 12(3):631-7. PubMed ID: 15289848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy.
    Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D
    Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
    Gonzalgo ML; Nakayama M; Lee SM; De Marzo AM; Nelson WG
    Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens.
    Woodson K; Gillespie J; Hanson J; Emmert-Buck M; Phillips JM; Linehan WM; Tangrea JA
    Prostate; 2004 Jun; 60(1):25-31. PubMed ID: 15129426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
    Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
    Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
    Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.
    Millar DS; Ow KK; Paul CL; Russell PJ; Molloy PL; Clark SJ
    Oncogene; 1999 Feb; 18(6):1313-24. PubMed ID: 10022813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MT1G hypermethylation is associated with higher tumor stage in prostate cancer.
    Henrique R; Jerónimo C; Hoque MO; Nomoto S; Carvalho AL; Costa VL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1274-8. PubMed ID: 15894685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
    Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
    Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A quantitative promoter methylation profile of prostate cancer.
    Jerónimo C; Henrique R; Hoque MO; Mambo E; Ribeiro FR; Varzim G; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    Clin Cancer Res; 2004 Dec; 10(24):8472-8. PubMed ID: 15623627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation analysis of BRCA1, RASSF1, GSTP1 and EPHB2 promoters in prostate biopsies according to different degrees of malignancy.
    Rabiau N; Thiam MO; Satih S; Guy L; Kemeny JL; Boiteux JP; Fontana L; Bignon YJ; Bernard-Gallon D
    In Vivo; 2009; 23(3):387-91. PubMed ID: 19454503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
    Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global expression analysis of prostate cancer-associated stroma and epithelia.
    Richardson AM; Woodson K; Wang Y; Rodriguez-Canales J; Erickson HS; Tangrea MA; Novakovic K; Gonzalez S; Velasco A; Kawasaki ES; Emmert-Buck MR; Chuaqui RF; Player A
    Diagn Mol Pathol; 2007 Dec; 16(4):189-97. PubMed ID: 18043281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
    Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
    Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation and histone modification regulate silencing of OPG during tumor progression.
    Lu TY; Kao CF; Lin CT; Huang DY; Chiu CY; Huang YS; Wu HC
    J Cell Biochem; 2009 Sep; 108(1):315-25. PubMed ID: 19565568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.